BK virus-associated nephropathy in renal alloqraft recipients: Rescue therapy by sirolimus-based immunosuppression

Transplantation

Volumn 78, Issue 7, 2004, Pages 1069-1073

  Wali, Ravinder K ^a,c   Drachenberg, Cinthia ^a   Hirsch, Hans H ^b   Papadimitriou, John ^a   Nahar, Anita ^a   Mohanlal, Viresh ^a   Brisco, Meredith A ^a   Bartlett, Stephen T ^a   Weir, Matthew R ^a   Ramos, Emilio ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Univ of Maryland School of Medicine ^*  (United States)

Author keywords

Acute rejection; BK virus nephropathy; Decoy cells; Immunosuppression; Kidney transplantation; Polyoma virus

Indexed keywords

ATORVASTATIN; BASILIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; BK VIRUS; CASE REPORT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MALE; NEPHRITIS; NEPHROTOXICITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION;

ADULT; BIOPSY; BK VIRUS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; SIROLIMUS; TRANSPLANTATION, HOMOLOGOUS; TUMOR VIRUS INFECTIONS;

EID: 6344276551     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000142127.84497.50     Document Type: Article

References (24)

1. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145-2151.
2. Petrogiannis-Haliotis T, Sakoulas G, Kirby J, et al. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med 2001; 345: 1250-1255.
3. Geetha D, Tong BC, Racusen L, et al. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation 2002; 73: 1933-1936.
4. Buehrig CK, Lager DJ, Stegall MD, et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003; 64: 665-673.
5. Drachenberg RC, Drachenberg CB, Papadimitriou JC, et al. Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant 2001; 1: 373-381.
6. Hodur DM, Mandelbrot D. Immunosuppression and BKV nephropathy. N Engl J Med 2002; 347: 2079-2080.
7. Binet I, Nickeleit V, Hirsch HH. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 1997; 342: 1315.
8. Howell DN, Smith SR, Butterly DW, et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation 1999; 68: 1279-1288.
9. Fishman JA. BK virus nephropathy - polyomavirus adding insult to injury. N Engl J Med 2002; 347: 527-530.
10. Celik B, Shapiro R, Vats A, et al. Polyomavirus allograft nephropathy: sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am J Transplant 2003; 3: 1378-1382.
11. Halloran PF. Sirolimus and cyclosporin for renal transplantation. Lancet 2000; 356: 179-180.
12. Poon M, Marx SO, Gallo R, et al. Rapamycin Inhibits Vascular Smooth Muscle Cell Migration. J Clin Invest 1996; 98: 2277-2283.
13. Atencio IA, Shadan FF, Zhou XJ, et al. Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. J Virol 1993; 67: 1424-1432.
14. Nankivell BJ, Gruenewald SM, Alien RD, et al. Predicting glomerular filtration rate after kidney transplantation. Transplantation 1995; 59: 1683-1689.
15. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488-496.
16. Randhawa PS, Vats A, Zygmunt D, et al. Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation 2002; 74: 485-488.
17. Hirsch HH, Mohaupt M, Klimkait T. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis 2001; 184: 1494-1495.
18. Kadambi PV, Josephson MA, Williams J, et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant 2003; 3: 186-191.
19. Poduval RD, Kadambi PV, Javaid B, et al. Leflunomide - a potential new therapeutic agent for BK nephropathy. American Society of Nephrology-Renal Week. November 15, 2003. Abstract.
20. Ginevri F, De Santis R, Comoli P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003; 75: 1266-1270.
21. Yewdell JW. Immunology. Hide and seek in the peptidome. Science 2003; 301: 1334-1335.
22. Shihab FS, Bennett WM, Yi H, et al. Combination therapy with sirolimus and mycophenolate mofetil: effects on the kidney and on transforming growth factor-beta1. Transplantation 2004; 77: 683-686.
23. Roy J, Paquette JS, Fortin JF, et al. The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother 2002; 46: 3447-3455.
24. Fishman JA. BK nephropathy: what is the role of antiviral therapy? Am J Transplant 2003; 3: 99-100.